Congratulations to our member PharmNovo!👍
PharmNovo is very pleased to announce that we have been awarded a € 2.5M grant and an opportunity for up to € 15M equity investment from the European Innovation Council and SMEs Executive Agency (EISMEA) for innovative pain treatment. The equity part being contingent on investments of equal amounts from co-investors. From a total number of 969 companies that submitted a full proposal, 347 companies were interviewed by juries of experienced investors and entrepreneurs. We are among the 68 startups selected out of 969 applicants, judged on the criteria of excellence, impact and risk level. Securing the maximum funding of € 17.5M award in blended financing available under the EIC Accelerator program, highlights the innovative potential of PN6047 and opens up vast opportunities and will strongly support our fundraising activities” states Per von Mentzer, CEO of PharmNovo. Our best regards and thank you to EIC for this award 🌟 Read the press release: https://lnkd.in/dTuzUPDD #neuropathicpain #lifescience #innovation #investmentopportunities #pharmnovo